Glyxambi: Medgend

Glyxambi FDA Approved Drugs

GLYXAMBI [Empagliflozin^{C₂₃H₂₇ClO₇} : Linagliptin^{C₂₅H₂₈N₈O₂}]

10mg : 5mg (oral tablet)

25mg : 5mg (oral tablet)

Boehringer Ingelheim^{Jan 30, 2015}

Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin (with or without insulin or a sulfonylurea).
Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin (with or without metformin).
Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin and metformin.
Method of treating type 2 diabetes mellitus by administering linagliptin in combination with empagliflozin.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.